Charles Schwab Investment Management Inc Abb Vie Inc. Transaction History
Charles Schwab Investment Management Inc
- $557 Billion
- Q2 2025
A detailed history of Charles Schwab Investment Management Inc transactions in Abb Vie Inc. stock. As of the latest transaction made, Charles Schwab Investment Management Inc holds 26,783,329 shares of ABBV stock, worth $5.32 Billion. This represents 0.89% of its overall portfolio holdings.
Number of Shares
26,783,329
Previous 25,266,107
6.0%
Holding current value
$5.32 Billion
Previous $5.29 Billion
6.09%
% of portfolio
0.89%
Previous 1.02%
Shares
32 transactions
Others Institutions Holding ABBV
# of Institutions
4,255Shares Held
1.28BCall Options Held
16.1MPut Options Held
14.9M-
Vanguard Group Inc Valley Forge, PA177MShares$35.2 Billion0.55% of portfolio
-
Black Rock Inc. New York, NY136MShares$27.1 Billion0.54% of portfolio
-
State Street Corp Boston, MA80MShares$15.9 Billion0.71% of portfolio
-
Jpmorgan Chase & CO New York, NY54.8MShares$10.9 Billion0.9% of portfolio
-
Morgan Stanley New York, NY41.1MShares$8.17 Billion0.63% of portfolio
About AbbVie Inc.
- Ticker ABBV
- Exchange NYSE
- Sector Healthcare
- Industry Drug Manufacturers—General
- Shares Outstandng 1,768,099,968
- Market Cap $351B
- Description
- AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...